Reports Hub

Consultation by: Department of Health and Social Care

Healthwatch Birmingham and Solihull responded to the government’s call for evidence on regulating AI in healthcare, emphasising the importance of transparency, clear consent processes and strong patient voice. We highlighted the need for patient feedback to form part of long term monitoring of AI systems, and for clear accountability when decisions are influenced by AI. We also called for national consistency in how AI use is communicated to patients, and stressed the importance of human safeguards, especially in higher risk areas such as mental health.

Consultation by: Department of Health and Social Care

Healthwatch Birmingham and Solihull responded to the government’s consultation on proposed changes to how NICE sets cost‑effectiveness thresholds. We raised concerns about risks to NICE’s independence and the potential for ministerial priorities to override clinical evidence, which could disadvantage people with rare or complex conditions. We warned that removing consultation requirements may limit patient voice and transparency. We also highlighted the risk of widening health inequalities if changes to thresholds are not fully assessed for their impact on public health.

Consultation by: Department of Health and Social Care

The Department of Health and Social Care consulted on proposals to allow pharmacists to substitute medicines when the prescribed item is unavailable. Healthwatch Birmingham & Solihull supported increased flexibility where it helps prevent delays to treatment. We emphasised the need for clear, accessible information for patients when substitutions are made, consistent monitoring of how decisions are applied, and notifying prescribers so they can respond to any follow up concerns. We recommended that dedicated training should be implemented ahead of the suggested changes. We also highlighted risks for patients who may struggle to understand changes without clear explanations and noted that strict word limits in the consultation restricted respondents’ ability to fully outline their views.

Consultation by: Department of Health and Social Care

The Department of Health and Social Care consulted on proposals to widen the range of medicines that Optometrists and Contact Lens Opticians can supply directly to patients. Healthwatch Birmingham & Solihull responded in support of measures that could improve access to timely care in community settings. We highlighted the need for clear referral pathways for patients who cannot be treated in the community, accessible information about the changes, and straightforward feedback and complaints routes. We also raised concerns about the potential for increased inequalities and the cost of medicines acting as a barrier for people on low incomes.